FDA gives the green light to Stimwave's mini spinal cord stimulator

With 510(k) clearance from the FDA in hand, Stimwave Technologies plans to hit the market in January with a tiny, wireless neuromodulation implant designed to treat chronic back and leg pain.

Stimwave Technologies won the FDA's 510(k) clearance for a wireless neuromodulation anti-pain device created with the idea that "smaller is better."

Food & Drug Administration (FDA), Stimwave Technologies

News Well, 510(k), Neuromodulation/Neurostimulation, Pain Management, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/12sY09r